Munchener Ruckvers (AMS:MEURV) PT Set at €260.00 by Independent Research

Share on StockTwits

Munchener Ruckvers (AMS:MEURV) received a €260.00 ($302.33) target price from equities research analysts at Independent Research in a report issued on Monday, Borsen Zeitung reports. The brokerage presently has a “neutral” rating on the stock.

A number of other research analysts also recently issued reports on MEURV. Royal Bank of Canada set a €240.00 ($279.07) price objective on Munchener Ruckvers and gave the stock a “buy” rating in a report on Wednesday, August 7th. Jefferies Financial Group set a €182.00 ($211.63) price objective on Munchener Ruckvers and gave the stock a “sell” rating in a report on Thursday, September 26th. Goldman Sachs Group set a €215.00 ($250.00) price objective on Munchener Ruckvers and gave the stock a “neutral” rating in a report on Friday, October 18th. Nord/LB set a €210.00 ($244.19) price objective on Munchener Ruckvers and gave the stock a “neutral” rating in a report on Monday, August 12th. Finally, UBS Group set a €200.00 ($232.56) price objective on Munchener Ruckvers and gave the stock a “sell” rating in a report on Monday. Two investment analysts have rated the stock with a sell rating, fourteen have given a hold rating and four have given a buy rating to the stock. The stock presently has a consensus rating of “Hold” and an average target price of €217.95 ($253.43).

Munchener Ruckvers has a fifty-two week low of €164.50 ($191.28) and a fifty-two week high of €200.00 ($232.56).

Further Reading: Is it better to buy a fund with a higher or lower NAV?

Analyst Recommendations for Munchener Ruckvers (AMS:MEURV)

Receive News & Ratings for Munchener Ruckvers Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Munchener Ruckvers and related companies with MarketBeat.com's FREE daily email newsletter.



Latest News

Zacks Investment Research Lowers Entasis Therapeutics  to Hold
Zacks Investment Research Lowers Entasis Therapeutics to Hold
ZTO Express   Stock Price Down 6.2%
ZTO Express Stock Price Down 6.2%
Exterran   Shares Down 7.6%
Exterran Shares Down 7.6%
Invivo Therapeutics   Shares Down 11.1%
Invivo Therapeutics Shares Down 11.1%
Pirate Chain Price Hits $0.0356 on Major Exchanges
Pirate Chain Price Hits $0.0356 on Major Exchanges
Extraction Oil & Gas  Stock Price Down 5.1%
Extraction Oil & Gas Stock Price Down 5.1%


 
© 2006-2019 Zolmax.